The 5th Global NASH Congress will take place in London on May 26-27. Surfing the NASH Tsunami is serving as a Media Partner for the event. Professor Ian Rowe and scientist/entrepreneur Rachel Zayas join Jörn Schattenberg, Louise Campbell and Roger Green to review some of the key presentations and discuss what attendees are likely to learn from the Congress.
The preliminary agenda for the Congress highlights five major areas of focus: recent updates in NASH pathogenesis; preclinical & translational strategy and new targets for treatment of NASH/fibrosis; non-invasive biomarkers and diagnostic tools; clinical development & clinical trial data and regulatory updates. The group examines conference presentations on these topics in the order presented here.